Curcumin treatment could inhibit HNSCC cell growth in vitro and in vivo by inhibiting the protein expression of p16, cyclin D1, phospho-Iκβ, and NF-κB [81]. The gene discussed is NFKB1; the disease is head and neck squamous cell carcinoma.